Drugs already there include GlaxoSmithKline (NYSE: GSK) and Roche's Boniva, Merck's (NYSE: MRK) Fosamax, Actonel from Procter & Gamble (NYSE: PG) and ...
NEW YORK (Reuters) - A Manhattan federal judge refused on Friday to dismiss a lawsuit alleging that Merck & Co Inc's osteoporosis drug Fosamax caused jaw ...
Fosamax was approved by FDA in October 1995, and has been used by more than 20 million people. The drug generated over $3 billion in annual sales for Merck ...
Maley's case is one of approximately 900 filed against Fosamax maker Merck, which has been accused of ignoring studies linking the osteoporosis drug to a ...
... generic-drug manufacturer, lost a bid in the Supreme Court of Canada to claim profit that Merck & Co. made from sales of the osteoporosis drug Fosamax...
The oral bisphosphonate drugs Chondronate® (pamidronate) and Fosamax® (alendronate) should be effective but have not been evaluated in randomized trials in ...
Many drugs, such as alendronate (Fosamax®), and raloxifene (Evista®), work by decreasing bone resorption. They can improve bone density by two to 10 percent ...
Email this story